- Home
- BRAG vs EDSA Comparison
BRAG vs EDSA Comparison
Compare BRAG & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRAG | EDSA |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.6M | 51.6M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BRAG | EDSA |
|---|---|---|
| Price | $1.62 | $5.68 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $6.00 | $5.00 |
| AVG Volume (30 Days) | 27.1K | ★ 53.1K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.67 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.42 | $0.72 |
| 52 Week High | $4.20 | $20.32 |
Technical Indicators
Market Signals| Indicator | BRAG | EDSA |
|---|---|---|
| Relative Strength Index (RSI) | 46.01 | 35.78 |
| Support Level | $1.52 | $4.80 |
| Resistance Level | $1.90 | $9.00 |
| Average True Range (ATR) | 0.15 | 0.60 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 46.74 | 26.19 |
Price Performance
Historical ComparisonAbout BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from Malta, and the rest from Netherlands, Curacao, the United States, Croatia, Marshall Islands, Brazil, Isle of Man, Belgium, Czech Republic, and other regions.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.